Day: February 16, 2025

12AM ET 02/17/2025 Newscast
Learn more about your ad choices. Visit podcastchoices.com/adchoices

NPR News: 02-16-2025 11PM EST Learn more about sponsor message choices: podcastchoices.com/adchoices NPR Privacy Policy

11PM ET 02/16/2025 Newscast
Learn more about your ad choices. Visit podcastchoices.com/adchoices

When Noland Arbaugh was left paralysed he signed up for an implant created by Musk’s Neuralink company that would allow his mind to directly interact with computers. Jenny Kleeman reports. Help support our independent journalism at theguardian.com/infocus

When Noland Arbaugh was left paralysed he signed up for an implant created by Musk’s Neuralink company that would allow his mind to directly interact with computers. Jenny Kleeman reports. Help support our independent journalism at theguardian.com/infocus

When Noland Arbaugh was left paralysed he signed up for an implant created by Musk’s Neuralink company that would allow his mind to directly interact with computers. Jenny Kleeman reports. Help support our independent journalism at theguardian.com/infocus

When Noland Arbaugh was left paralysed he signed up for an implant created by Musk’s Neuralink company that would allow his mind to directly interact with computers. Jenny Kleeman reports. Help support our independent journalism at theguardian.com/infocus

When Noland Arbaugh was left paralysed he signed up for an implant created by Musk’s Neuralink company that would allow his mind to directly interact with computers. Jenny Kleeman reports. Help support our independent journalism at theguardian.com/infocus

When Noland Arbaugh was left paralysed he signed up for an implant created by Musk’s Neuralink company that would allow his mind to directly interact with computers. Jenny Kleeman reports. Help support our independent journalism at theguardian.com/infocus

When Noland Arbaugh was left paralysed he signed up for an implant created by Musk’s Neuralink company that would allow his mind to directly interact with computers. Jenny Kleeman reports. Help support our independent journalism at theguardian.com/infocus